Edition:
United States

People: ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

2.82USD
11:45am EDT
Change (% chg)

$-0.10 (-3.42%)
Prev Close
$2.92
Open
$2.93
Day's High
$2.93
Day's Low
$2.81
Volume
84,157
Avg. Vol
506,254
52-wk High
$18.71
52-wk Low
$2.69

Morris, Charles 

Dr. Charles Q. Morris is Executive Vice President and Chief Development Officer of ImmunoGen, Inc. effective November 26, 2012. Dr. Morris joined ImmunoGen in November 2012, and has served as our Executive Vice President and Chief Development Officer since that date. Prior to joining ImmunoGen, he served as Executive Vice President and Chief Medical Officer of Allos Therapeutics, Inc., a biotechnology company, from 2010 until its acquisition in 2012. Prior to that he served as Vice President, Worldwide Clinical Research, at Cephalon, Inc., a biotechnology company, from 2008 to 2010. Dr. Morris holds his medical degrees from Sheffield University Medical School and is a member of the Royal College of Physicians of London.

Basic Compensation

Total Annual Compensation, USD 665,010
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 780,420
Fiscal Year Total, USD 1,445,430

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 27,746 144,410.00